Company: FITBI
Filing Date: 2025-02-24
Form Type: 10-K
Source: 0000035527-25-000079
Chunk: 158

Company: FIFTH THIRD BANCORP
Filing Date: 2025-02-24
Form: 10-K
Item: Item 7A
Chunk 158
---
2022, respectively. No stock options vested during the years ended December 31, 2024 and 2023 and an immaterial amount of stock options vested during the year ended December 31, 2022. As of December 31, 2024, the aggregate intrinsic value of both outstanding stock options and exercisable stock options was $2 million.The following table summarizes stock options activity for the years ended December 31:202420232022Stock Options (in thousands, except per share data)  Number of OptionsWeighted-Average Exercise Price Per ShareNumber of OptionsWeighted-Average Exercise Price Per ShareNumber of OptionsWeighted-Average Exercise Price Per ShareOutstanding at January 1224 $21.45 312 $21.65 409 $21.51 Exercised(129)21.03 (86)21.97 (97)21.06 Forfeited or expired— — (2)27.71 — — Outstanding at December 3195 $22.03 224 $21.45 312 $21.65 Exercisable at December 3195 $22.03 224 $21.45 312 $21.65 The following table summarizes outstanding and exercisable stock options by exercise price per share at December 31, 2024:Outstanding Stock OptionsExercisable Stock OptionsStock Options (in thousands, except per share data)Number of OptionsWeighted-Exercise Price Per ShareWeighted-Average Remaining Contractual Life (in years)Number of OptionsWeighted-Exercise Price Per ShareWeighted-Average Remaining Contractual Life (in years)$10.01-$20.0050 18.58 0.850 18.58 0.8$20.01-$30.0045 25.86 2.845 25.86 2.8All stock options95 $22.03 1.895 $22.03 1.8Other Stock-Based Compensation  PSAs are payable contingent upon the Bancorp achieving certain predefined performance targets over a three-year measurement period. Depending on performance, between zero and 1.2 million shares may be released to settle the PSAs outstanding at December 31, 2024 once the applicable performance periods are completed. Awards granted during the years ended December